The Medicines Co. (NASDAQ:MDCO) exercised its option to acquire Annovation Biopharma Inc. (Cambridge, Mass.) for $28.4 million in cash up front. Annovation
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury